Quality-adjusted survival (Q-TWiST) analysis of EORTC trial 30853: comparing goserelin acetate and flutamide with bilateral orchiectomy in patients with metastatic prostate cancer. European Organization for Research and Treatment of Cancer.
about
Q-TWiST analysis to estimate overall benefit for patients with metastatic renal cell carcinoma treated in a phase III trial of sunitinib vs interferon-α.Pain and health-related quality of life in a geographically defined population of men with prostate cancer.Quality-adjusted time without symptoms or toxicity (Q-TWiST): patient-reported outcome or mathematical model? A systematic review in cancer.Changes in health utilities and health-related quality of life over 12 months following radical prostatectomy.A mini-review of quality of life as an outcome in prostate cancer trials: patient-centered approaches are needed to propose appropriate treatments on behalf of patients.
P2860
Quality-adjusted survival (Q-TWiST) analysis of EORTC trial 30853: comparing goserelin acetate and flutamide with bilateral orchiectomy in patients with metastatic prostate cancer. European Organization for Research and Treatment of Cancer.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh-hant
name
Quality-adjusted survival (Q-T ...... earch and Treatment of Cancer.
@en
Quality-adjusted survival
@nl
type
label
Quality-adjusted survival (Q-T ...... earch and Treatment of Cancer.
@en
Quality-adjusted survival
@nl
prefLabel
Quality-adjusted survival (Q-T ...... earch and Treatment of Cancer.
@en
Quality-adjusted survival
@nl
P2093
P2860
P1433
P1476
Quality-adjusted survival (Q-T ...... search and Treatment of Cancer
@en
P2093
P2860
P304
P356
10.1002/(SICI)1097-0045(19990201)38:2<100::AID-PROS3>3.0.CO;2-X
P577
1999-02-01T00:00:00Z